Last Updated: November 16, 2026

Details for Patent: 11,752,154

« Back to Dashboard


Which drugs does patent 11,752,154 protect, and when does it expire?

Patent 11,752,154 protects SEPHIENCE and is included in one NDA.

This patent has nine patent family members in seven countries.

Summary for Patent: 11,752,154
Title:Pharmaceutical compositions comprising sepiapterin and uses thereof
Abstract:The present invention features pharmaceutical compositions including sepiapterin, or a pharmaceutically acceptable salt and/or co-crystal thereof, and methods for the treatment of tetrahydrobiopterin-related disorders (e.g., tetrahydrobiopterin deficiency or phenylketonuria) with such compositions.
Inventor(s):Daniel E. Levy
Assignee: PTC Therapeutics MP Inc
Application Number:US16/670,362
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 11,752,154

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Ptc Therap SEPHIENCE sepiapterin POWDER;ORAL 219666-002 Jul 28, 2025 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y TREATMENT OF HYPERPHENYLALANINEMIA (HPA) IN ADULT AND PEDIATRIC PATIENTS WITH SEPIAPTERIN-RESPONSIVE PHENYLKETONURIA (PKU) BY ADMINISTERING SEPIAPTERIN ⤷  Start Trial
Ptc Therap SEPHIENCE sepiapterin POWDER;ORAL 219666-001 Jul 28, 2025 RX Yes No ⤷  Start Trial ⤷  Start Trial Y TREATMENT OF HYPERPHENYLALANINEMIA (HPA) IN ADULT AND PEDIATRIC PATIENTS WITH SEPIAPTERIN-RESPONSIVE PHENYLKETONURIA (PKU) BY ADMINISTERING SEPIAPTERIN ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.